Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 26.22
+0.20 (0.77%)
Oct 31, 2025, 3:04 PM CST
SHE:300702 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 191.75 | 55.94 | 27.36 | -118.87 | 204.68 | 667.06 | Upgrade |
Depreciation & Amortization | 331.72 | 332.38 | 305.13 | 254.94 | 193.42 | 136.1 | Upgrade |
Other Amortization | 4.23 | 3.57 | 1.73 | 1.04 | 0.56 | 0.66 | Upgrade |
Loss (Gain) From Sale of Assets | -0.72 | -0.72 | 0.03 | 0.02 | -0.06 | -0.21 | Upgrade |
Asset Writedown & Restructuring Costs | 2.67 | 2.67 | 2.09 | 8.21 | 46.49 | 17.15 | Upgrade |
Loss (Gain) From Sale of Investments | 30.4 | 30.4 | 62.69 | 59.65 | -52.72 | -68.37 | Upgrade |
Provision & Write-off of Bad Debts | -0.9 | -1.37 | 6.3 | -3.87 | - | - | Upgrade |
Other Operating Activities | -158.94 | 93.95 | 181.3 | 92.4 | 26.91 | 40.65 | Upgrade |
Change in Accounts Receivable | -363.45 | -363.45 | -242.68 | -269.46 | -315.07 | -326.32 | Upgrade |
Change in Inventory | -32.85 | -32.85 | -12.72 | -515.15 | -763.47 | -140.19 | Upgrade |
Change in Accounts Payable | 216.62 | 216.62 | -340.18 | 450.23 | 355.46 | 275.12 | Upgrade |
Change in Other Net Operating Assets | 5.77 | 5.77 | -34.67 | -2.46 | 40.51 | 14.86 | Upgrade |
Operating Cash Flow | 228.03 | 344.64 | -43.9 | -48.7 | -262.23 | 622.18 | Upgrade |
Operating Cash Flow Growth | -46.36% | - | - | - | - | 45.42% | Upgrade |
Capital Expenditures | -257.4 | -168.95 | -316.81 | -527.01 | -736.39 | -506.05 | Upgrade |
Sale of Property, Plant & Equipment | 2.8 | 1.42 | 3.56 | 4.11 | 0.77 | 0.74 | Upgrade |
Cash Acquisitions | - | - | 0.35 | - | -5.64 | -37.7 | Upgrade |
Investment in Securities | -46.2 | -13.75 | 2.5 | 22.5 | -118.7 | 13.88 | Upgrade |
Other Investing Activities | -0.66 | -36.02 | -44.95 | -20.42 | 57.59 | 11.83 | Upgrade |
Investing Cash Flow | -301.47 | -217.3 | -355.35 | -520.82 | -802.37 | -517.3 | Upgrade |
Long-Term Debt Issued | - | 1,897 | 2,184 | 1,409 | 837.47 | 465.08 | Upgrade |
Total Debt Issued | 2,257 | 1,897 | 2,184 | 1,409 | 837.47 | 465.08 | Upgrade |
Long-Term Debt Repaid | - | -1,869 | -1,690 | -752.92 | -495.14 | -255.59 | Upgrade |
Total Debt Repaid | -2,208 | -1,869 | -1,690 | -752.92 | -495.14 | -255.59 | Upgrade |
Net Debt Issued (Repaid) | 48.99 | 27.79 | 494.47 | 656.52 | 342.33 | 209.49 | Upgrade |
Issuance of Common Stock | 0.21 | - | - | - | - | 895.75 | Upgrade |
Repurchase of Common Stock | -41.04 | -27.79 | - | -58 | -0.24 | - | Upgrade |
Common Dividends Paid | -60.92 | -70.19 | -51.12 | -69.42 | -112.43 | -94.94 | Upgrade |
Other Financing Activities | 48.49 | 93.04 | -80 | -9.76 | - | 0.2 | Upgrade |
Financing Cash Flow | -4.26 | 22.85 | 363.35 | 519.34 | 229.67 | 1,011 | Upgrade |
Foreign Exchange Rate Adjustments | 19.75 | 20.43 | -1.89 | 12.93 | -6.15 | -20.53 | Upgrade |
Net Cash Flow | -57.95 | 170.62 | -37.79 | -37.25 | -841.09 | 1,095 | Upgrade |
Free Cash Flow | -29.37 | 175.69 | -360.71 | -575.71 | -998.62 | 116.13 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | 57.49% | Upgrade |
Free Cash Flow Margin | -0.98% | 6.68% | -14.27% | -21.59% | -39.24% | 4.49% | Upgrade |
Free Cash Flow Per Share | -0.09 | 0.50 | -1.05 | -1.65 | -2.88 | 0.36 | Upgrade |
Cash Income Tax Paid | - | 5.3 | -32.25 | -286.68 | -54.41 | -21.79 | Upgrade |
Levered Free Cash Flow | 67.55 | 378.71 | -527.06 | -415.35 | -747.26 | 141.39 | Upgrade |
Unlevered Free Cash Flow | 75.81 | 412.5 | -495.87 | -394.2 | -737.06 | 144.15 | Upgrade |
Change in Working Capital | -172.19 | -172.19 | -630.52 | -342.22 | -681.5 | -170.87 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.